Gaithersburg, MD, United States of America

Yue Wang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Medimmune Limited. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yue Wang. Retrieved from https://idiyas.com/inventor/yue-wang-70m4eyyu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yue Wang - Innovator in Binding Proteins

Introduction

Yue Wang is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of binding proteins that have potential therapeutic applications.

Latest Patents

Yue Wang holds a patent for "Bispecific PD-1 and TIGIT binding proteins and uses thereof." This patent relates to binding proteins, including antibodies, that specifically bind to Programmed Death-1 (PD-1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT). The disclosure provides compositions comprising such binding proteins and nucleic acid molecules encoding them. Furthermore, it outlines methods for treating various disorders or conditions using these innovative binding proteins.

Career Highlights

Yue Wang is currently employed at MedImmune Limited, where she continues to advance her research and development efforts. Her work focuses on creating novel therapeutic solutions that can improve patient outcomes in immunotherapy.

Collaborations

Yue collaborates with esteemed colleagues, including Yariv Mazor and Gordon Moody, who contribute to her research initiatives and help drive innovation within the company.

Conclusion

Yue Wang's contributions to the field of binding proteins exemplify her dedication to advancing medical science. Her innovative work has the potential to lead to significant breakthroughs in the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…